← Leaderboards
George Walter Koszalka
Neurop, Inc.
$3,138,178
Attributed
$5,974,036
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2011–20$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,974,036 · 3
By mechanism
U44$3,507,824 · 1
R44$2,163,892 · 1
R43$302,320 · 1
Top collaborators
- Scott James Myers8 shared
- Robert Zaczek1 shared
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalDoseSafetyPharmaceutical PreparationsPropertyAdverse EffectsPharmacologyPharmacologic SubstancePre-Clinical ModelN-Methyl-D-Aspartate ReceptorsAneurysmNeuroprotectionOperative Surgical ProceduresCostDisabilityEventBrain InjuriesDose-LimitingBrainCerebral IschemiaNeuroprotective AgentsN-MethylaspartateClinical TrialsLead
Grant awards (10)
Targeting TRP channels for novel topical treatment of atopic dermatitis$302,320
R43 · FY2020 · AI · contact PI
Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective, Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage$2,163,892
R44 · FY2017 · NS
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$393,610
U44 · FY2015 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$48,422
U44 · FY2015 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$5,000
U44 · FY2015 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$748,822
U44 · FY2014 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$86,250
U44 · FY2014 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$994,652
U44 · FY2013 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$931,527
U44 · FY2012 · NS · contact PI
Pre-clinical Development of a Context-Dependent NMADR Neuroprotectant for Treatme$299,541
U44 · FY2011 · NS · contact PI